These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 186481)

  • 1. Modification of renin reactivity by lipids extracted from normal, hypertensive, and uremic plasma.
    Kotchen TA; Talwalker RT; Miller MC; Welch WJ
    J Clin Endocrinol Metab; 1976 Nov; 43(5):971-81. PubMed ID: 186481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the existence of an acetone soluble renin inhibiting factor in normal human plasma.
    Kotchen TA; Talwalkar RT; Kotchen JM; Miller MC; Welch WJ
    Circ Res; 1975 Jun; 36(6 Suppl 1):17-27. PubMed ID: 1132076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence against acetone-soluble renin inhibitors in normal human plasma.
    Druilhet RE; Overturf ML; Hinshaw RA; Kirkendall WM
    Hypertension; 1979; 1(2):98-105. PubMed ID: 399942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin reactivity in plasma of patients with normal renin and low renin essential hypertension.
    Brooks CS; Talwalker RT; Kotchen TA
    J Clin Endocrinol Metab; 1977 Feb; 44(2):322-9. PubMed ID: 838842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of renin inhibitors in normal and uremic plasma.
    Kotchen TA; Talwalkar RT; Kaul K
    J Lab Clin Med; 1985 Mar; 105(3):286-93. PubMed ID: 3882863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the in vitro renin reaction by circulating neutral lipids.
    Kotchen TA; Talwalkar RT; Welch WJ
    Circ Res; 1977 Oct; 41(4 Suppl 2):46-8. PubMed ID: 902372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin reactivity in normal, hypertensive, and uremic plasma.
    Kotchen TA; Rice TW; Walters DR
    J Clin Endocrinol Metab; 1972 Jun; 34(6):928-37. PubMed ID: 4336459
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased enzymatic activity of renin and hyperlipidemia.
    Kotchen TA; Talwalkar RT
    Am J Physiol; 1981 Jan; 240(1):E60-4. PubMed ID: 7006415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral contraceptive therapy on the renin-angiotensin system in normotensive and hypertensive women.
    Tapia HR; Johnson CE; Strong CG
    Obstet Gynecol; 1973 May; 41(5):643-9. PubMed ID: 4348864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic activity of renin in plasma of normal and uraemic subjects.
    Kotchen TA; Guyenne TT; Corvol P; Menard J
    Clin Sci (Lond); 1984 Sep; 67(3):365-8. PubMed ID: 6380890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma renin activity, reactivity, concentration and substrate following hypertension during pregnancy. Effect of oral contraceptive agents.
    Kotchen TA; Kotchen JM; Guthrie GP; Cottrill CM
    Hypertension; 1979; 1(4):355-61. PubMed ID: 396239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic hypertension and plasma renin activity in children with the hemolytic-uremic syndrome.
    Grunfeld B; Gimenez M; Liapchuc S; Mendilaharzu J; Gianantonio C
    Int J Pediatr Nephrol; 1982 Sep; 3(3):211-4. PubMed ID: 6754646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local angiotensin formation in hindlimbs of uremic hypertensive and renovascular hypertensive rats.
    Kuczera M; Hilgers KF; Lisson C; Ganten D; Hilgenfeldt U; Ritz E; Mann JF
    J Hypertens; 1991 Jan; 9(1):41-8. PubMed ID: 1848258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A circulating renin activator in essential hypertension.
    Sambhi MP; Eggena P; Barrett JC; Tuck M; Wiedeman CE; Thananopavarn C
    Circ Res; 1975 Jun; 36(6 Suppl 1):28-37. PubMed ID: 805672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin reactivity, renin activity and renin concentration in patients with normal and low renin essential hypertension.
    McDonald WJ; Cohen EL; Conn JW
    J Clin Endocrinol Metab; 1977 Oct; 45(4):685-90. PubMed ID: 914973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plasma inhibitor of the renin-antirenin reaction and the in vitro generation of angiotensin I.
    Lucas CP; Waldhausl WK; Cohen EL; Berlinger FG; McDonald WJ; Sider RS
    Metabolism; 1975 Feb; 24(2):127-38. PubMed ID: 163425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB; Johnson A; Gabow PA; Schrier RW
    N Engl J Med; 1990 Oct; 323(16):1091-6. PubMed ID: 2215576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma prorenin in normal, hypertensive, and anephric subjects and its effect on renin measurements.
    Sealey JE; Moon C; Laragh JH; Atlas SA
    Circ Res; 1977 May; 40(5 Suppl 1):I41-5. PubMed ID: 870230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.